Funded Startups in Wellesley
Seven funded companies are listed for Wellesley, spanning round dates from 2020-10-06 (Talaris Therapeutics, $115M) to 2025-08-20 (Vanguard Renewables, und…
Seven funded companies are listed for Wellesley, spanning round dates from 2020-10-06 (Talaris Therapeutics, $115M) to 2025-08-20 (Vanguard Renewables, undisclosed). The largest disclosed round, $115M on 2020-10-06, dwarfs the rest of the disclosed amounts, with the next-largest being Truvideo’s $40M (2024-12-10); most other disclosed rounds sit below that level (e.g., Scripta Insights $17M on 2024-12-18; Auron Therapeutics $27M on 2025-02-04; Allurion Technologies $3M on 2025-01-14; RevOps Health $2M on 2024-10-10). A tight temporal cluster appears in late 2024 and early 2025: three disclosed rounds fall in Dec 2024 (Scripta Insights 2024-12-18 $17M, Truvideo 2024-12-10 $40M) and the pipeline continues into 2025 (Allurion Technologies 2025-01-14 $3M; Auron Therapeutics 2025-02-04 $27M). Sector-wise, Biotechnology appears in 2 of 7 entries (Auron Therapeutics 2025-02-04; Talaris Therapeutics 2020-10-06), while multiple entries are tagged “Series Unknown” (4 of 7) and one is “undisclosed” by amount (Vanguard Renewables, 2025-08-20).
Most recent rounds
7 shownRelated listings
Frequently asked
Which disclosed round is the size outlier for Wellesley, and how does it compare to the rest of the disclosed amounts?
Talaris Therapeutics’ $115M round on 2020-10-06 is an outlier, with the next-largest disclosed amount at $40M (Truvideo on 2024-12-10). Several other disclosed rounds are much smaller, including RevOps Health at $2M (2024-10-10) and Allurion Technologies at $3M (2025-01-14).
Do the most recent entries cluster in a narrow timeframe?
Yes. Excluding the 2025-08-20 undisclosed Vanguard Renewables entry, the list shows multiple rounds concentrated from 2024-12-10 through 2025-02-04: Truvideo ($40M, 2024-12-10), Scripta Insights ($17M, 2024-12-18), Allurion Technologies ($3M, 2025-01-14), and Auron Therapeutics ($27M, 2025-02-04).
How much of this Wellesley list is missing disclosed round size or stage classification?
Amount disclosure is incomplete for Vanguard Renewables on 2025-08-20 (undisclosed), while disclosed amounts appear for 6 of 7 entries. Stage classification is also incomplete: 4 of 7 rows are labeled “Series Unknown” (Vanguard Renewables, Allurion Technologies, RevOps Health, Truvideo), with only Auron Therapeutics and Scripta Insights marked as Series B and Talaris Therapeutics missing a stage label.
What stage pattern dominates among disclosed and labeled rounds in this list?
For the labeled stages, Series B accounts for 2 of 7 entries: Auron Therapeutics ($27M, 2025-02-04) and Scripta Insights ($17M, 2024-12-18). The remaining 5 entries either use “Series Unknown” or leave stage blank, including the large $115M Talaris Therapeutics entry dated 2020-10-06.
Are any sectors over-represented compared with others in the Wellesley set shown here?
Biotechnology appears in 2 of the 7 entries (Auron Therapeutics in 2025-02-04 and Talaris Therapeutics in 2020-10-06). The other sectors in this slice are each represented by a single company: Agriculture and Farming (Vanguard Renewables), Health Care (Allurion Technologies and Scripta Insights, but those are counted separately in the rows), Information Technology (Truvideo), and Data and Analytics (RevOps Health).
Which entries fall closest to the latest round date in this table?
The latest row is Vanguard Renewables on 2025-08-20 (amount undisclosed). The next-closest disclosed rounds are Auron Therapeutics on 2025-02-04 ($27M), Allurion Technologies on 2025-01-14 ($3M), and Scripta Insights on 2024-12-18 ($17M), showing a late-2024 to early-2025 activity window leading up to the 2025-08-20 entry.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.